These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 9988141)
1. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity. Calò L; Davis PA; Milani M; Cantaro S; Antonello A; Favaro S; D'Angelo A Clin Nephrol; 1999 Jan; 51(1):12-7. PubMed ID: 9988141 [TBL] [Abstract][Full Text] [Related]
2. Miscellaneous non-inflammatory musculoskeletal conditions. Bartter's and Gitelman's diseases. Favero M; Calò LA; Schiavon F; Punzi L Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):637-48. PubMed ID: 22142744 [TBL] [Abstract][Full Text] [Related]
3. Reduced mRNA and protein content of rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes: relevance for the pathophysiology of hypertension. Pagnin E; Semplicini A; Sartori M; Pessina AC; Calò LA Am J Hypertens; 2005 Sep; 18(9 Pt 1):1200-5. PubMed ID: 16182110 [TBL] [Abstract][Full Text] [Related]
4. Paradoxes in magnesium transport in type 1 Bartter's syndrome and Gitelman's syndrome: a modeling analysis. Dutta P; Layton AT Am J Physiol Renal Physiol; 2024 Sep; 327(3):F386-F396. PubMed ID: 38991009 [TBL] [Abstract][Full Text] [Related]
5. [The Gitelman syndrome--a differential diagnosis of Bartter syndrome]. Zimmermann J; Reincke M; Schramm L; Harlos J; Allolio B Med Klin (Munich); 1994 Dec; 89(12):640-4. PubMed ID: 7869998 [TBL] [Abstract][Full Text] [Related]
6. Chondrocalcinosis is a feature of Gitelman's variant of Bartter's syndrome. A new look at the hypomagnesemia associated with calcium pyrophosphate dihydrate crystal deposition disease. Punzi L; Calò L; Schiavon F; Pianon M; Rosada M; Todesco S Rev Rhum Engl Ed; 1998 Oct; 65(10):571-4. PubMed ID: 9809361 [TBL] [Abstract][Full Text] [Related]
7. Hypokalemic nephropathy in an adult patient with partial empty sella: a classic Bartter's syndrome, a Gitelman's syndrome or both? Addolorato G; Ancarani F; Leggio L; Abenavoli L; de Lorenzi G; Montalto M; Staffolani E; Zannoni GF; Costanzi S; Gasbarrini G Panminerva Med; 2006 Jun; 48(2):137-42. PubMed ID: 16953151 [TBL] [Abstract][Full Text] [Related]
8. [Bartter's syndrome: new classification, old therapy]. Peco-Antic A; Dudic S; Marsenic O; Zivic G Srp Arh Celok Lek; 2001; 129(5-6):139-42. PubMed ID: 11797462 [TBL] [Abstract][Full Text] [Related]
9. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes. Calò LA; Pagnin E; Ceolotto G; Davis PA; Schiavo S; Papparella I; Semplicini A; Pessina AC J Hypertens; 2008 May; 26(5):938-45. PubMed ID: 18398336 [TBL] [Abstract][Full Text] [Related]
10. Bartter's and Gitelman's syndromes: from gene to clinic. Naesens M; Steels P; Verberckmoes R; Vanrenterghem Y; Kuypers D Nephron Physiol; 2004; 96(3):p65-78. PubMed ID: 15056980 [TBL] [Abstract][Full Text] [Related]
11. Molecular pathophysiology of Bartter's and Gitelman's syndromes. Koulouridis E; Koulouridis I World J Pediatr; 2015 May; 11(2):113-25. PubMed ID: 25754753 [TBL] [Abstract][Full Text] [Related]
12. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Simon DB; Karet FE; Hamdan JM; DiPietro A; Sanjad SA; Lifton RP Nat Genet; 1996 Jun; 13(2):183-8. PubMed ID: 8640224 [TBL] [Abstract][Full Text] [Related]
13. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Simon DB; Nelson-Williams C; Bia MJ; Ellison D; Karet FE; Molina AM; Vaara I; Iwata F; Cushner HM; Koolen M; Gainza FJ; Gitleman HJ; Lifton RP Nat Genet; 1996 Jan; 12(1):24-30. PubMed ID: 8528245 [TBL] [Abstract][Full Text] [Related]
14. Constitutive nitric oxide synthase gene expression in Bartter's and Gitelman's syndrome and its relationship to their vascular hyporesponsiveness. Calò L; Bordin MC; Davis PA; Cantaro S; Milani M; Gandolfi L; Favaro S; Antonello A; Fagiolo U; D'Angelo A Contrib Nephrol; 1997; 122():193-5. PubMed ID: 9399065 [No Abstract] [Full Text] [Related]
15. Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes. Calò LA; Maiolino G J Endocrinol Invest; 2015 Jul; 38(7):711-6. PubMed ID: 25740064 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension. Calò LA; Pagnin E; Davis PA; Sartori M; Ceolotto G; Pessina AC; Semplicini A J Clin Endocrinol Metab; 2004 Aug; 89(8):4153-7. PubMed ID: 15292363 [TBL] [Abstract][Full Text] [Related]
17. Renal tubular function in children and adolescents with Gitelman's syndrome, the hypocalciuric variant of Bartter's syndrome. Peters N; Bettinelli A; Spicher I; Basilico E; Metta MG; Bianchetti MG Nephrol Dial Transplant; 1995; 10(8):1313-9. PubMed ID: 8538920 [TBL] [Abstract][Full Text] [Related]
18. Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients. Calò LA; Davis PA; Pagnin E; Dal Maso L; Maiolino G; Seccia TM; Pessina AC; Rossi GP J Hypertens; 2014 Feb; 32(2):331-8. PubMed ID: 24356540 [TBL] [Abstract][Full Text] [Related]
19. Hypokalemic metabolic alkalosis--three case reports. Galesić K; Bozić B; Sćukanec-Spoljar M; Morović-Vergles J; Cvitković-Kuzmić A; Ljubanović D Acta Med Croatica; 2001; 55(4-5):219-23. PubMed ID: 12398028 [TBL] [Abstract][Full Text] [Related]
20. Problems in diagnosing atypical Gitelman's syndrome presenting with normomagnesaemia. Nakamura A; Shimizu C; Nagai S; Yoshida M; Aoki K; Kondo T; Miyoshi H; Wada N; Tajima T; Terauchi Y; Yoshioka N; Koike T Clin Endocrinol (Oxf); 2010 Feb; 72(2):272-6. PubMed ID: 19508680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]